RARITAN, N.J., Oct. 5, 2011 /PRNewswire/ -- Today Scios Inc.

Pharmaceutical Companies Allegedly Marketed the Drug Natrecor for a Use Not Approved By the Food and Drug Administration WASHINGTON, Feb.

MOUNTAIN VIEW, Calif., June 8 /PRNewswire/ -- Scios Inc.

By Steve JohnsonSTAFF A new study bolsters the contention of executives at Mountain View-based Scios Inc. that their controversial heart drug, Natrecor, is safe -- although the study found the drug didn't help patients receiving it regularly in outpatient clinics.

FREMONT, Calif., Nov. 13 /PRNewswire/ -- Scios Inc.